Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
Altar is a French biotech company founded in 2017, specialized in Adaptive Laboratory Evolution. The company developed in the last years a technology enabling the continuous, uninterrupted cultivation of microorganisms' cultures under controlled conditions to select strains with specific properties, for as long as required. The start-up offers access to its technology, platform and associated know-how through collaborative projects or research services. Thanks to the high maturity of their approach of ALE, Altar has a high degree of precision and control over their technology, which is directly linked to the team's know-how and the R&D assets they developed. "At Lesaffre, we are driven by an unwavering belief in the infinite possibilities of fermentation," says Brice-Audren Riché, CEO of Lesaffre. "Powered by the incredible potential of microorganisms, we see fermentation as a transformative solution to nourish a growing global population in a safer, healthier, and more sustainable
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]Yahoo! Finance
- NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal AgriculturePR Newswire
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target raised by analysts at TD Cowen from $3.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNAGlobeNewswire
DNA
Earnings
- 8/8/24 - Miss
DNA
Analyst Actions
- 8/23/24 - BTIG
DNA
Sec Filings
- 10/17/24 - Form 144
- 10/16/24 - Form 144
- 10/15/24 - Form 144
- DNA's page on the SEC website